Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stage IA Uterine Sarcoma 1Ependymoma 1Anus Neoplasms 1

Interventions

Fluorouracil 14Radiotherapy 11Mitomycin 9Radiation 8Capecitabine 8Surveys and Questionnaires 6Drug Therapy 6Cisplatin 6pembrolizumab 5Paclitaxel 4Magnetic Resonance Spectroscopy 4Irinotecan 3Immune Checkpoint Inhibitors 3Cetuximab 3Carboplatin 3Biopsy 3tislelizumab 2durvalumab 2atezolizumab 2aldesleukin 2Therapeutics 2Specimen Handling 2Papillomavirus Vaccines 2Oxaliplatin 2Observation 2Nivolumab 2Cyclophosphamide 2Blood Specimen Collection 2Adoptive Transfer 2toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anus Neoplasms × Linear Energy Transfer × Clear all
NCT03690921 2023-06-29

Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial

M.D. Anderson Cancer Center

Phase 2 Completed
8 enrolled 12 charts
Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡